Prenatal Effects of Nicotine on Obesity Risks: A Narrative Review

Olivia White1,2, Nicole Roeder1,2, Kenneth Blum3

  • 1Behavioral Neuropharmacology and Neuroimaging Laboratory on Addictions (BNNLA), Clinical Research Institute on Addictions, Department of Pharmacology and Toxicology, Jacobs School of Medicine and Biomedical Sciences, University at Buffalo, Buffalo, NY 14203, USA.

Insights

Prenatal nicotine exposure is linked to lower birth weight and increased childhood obesity risk. This may stem from various factors, including genetic predispositions, impacting long-term metabolic health.

Area of Science:

  • Developmental Pediatrics
  • Public Health
  • Genetics and Obesity Research

Background:

  • Maternal nicotine use during pregnancy is associated with adverse child health outcomes.
  • Prenatal nicotine exposure is a risk factor for low birth weight and subsequent obesity development.
  • Obesity in children and adolescents increases the risk of metabolic comorbidities like diabetes and liver disease.

Purpose of the Study:

  • To explore the link between prenatal nicotine exposure and childhood obesity.
  • To review theories explaining nicotine's impact on weight gain and metabolic health.
  • To highlight the role of genetic factors in obesity risk for exposed children.

Main Methods:

  • Literature review examining existing theories on nicotine's effects on fetal development and obesity.
  • Analysis of studies investigating the relationship between prenatal nicotine exposure and birth weight.
  • Exploration of genetic associations, such as the DRD2 A1 variant, with obesity risk in exposed populations.

Main Results:

  • Children exposed to nicotine in utero often exhibit lower birth weights.
  • Prenatal nicotine exposure elevates the risk of overweight and obesity throughout childhood and adolescence.
  • Genetic factors, including specific risk alleles, may mediate the predisposition to obesity.

Conclusions:

  • Prenatal nicotine exposure poses a significant risk for developing obesity and related metabolic diseases.
  • Understanding the mechanisms, including genetic influences, is crucial for targeted interventions.
  • Early prevention and intervention strategies are vital for children exposed to nicotine prenatally to mitigate long-term health risks.

Related Concept Videos

Stress Prevention and Stress Management Techniques IV01:26

Stress Prevention and Stress Management Techniques IV

Stress often leads to unhealthy habits like smoking, excessive drinking, and overeating, which offer short-term relief but ultimately increase long-term health risks. These behaviors create a cycle that temporarily lowers stress levels but can result in severe long-term health consequences. Breaking these habits is essential to reduce the risk of chronic diseases and improve overall well-being. Three primary changes that support better health include quitting smoking, reducing alcohol intake,...
57
Drugs Acting on Autonomic Ganglia: Stimulants01:23

Drugs Acting on Autonomic Ganglia: Stimulants


Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating...
1.5K
Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
601
Stimulants01:29

Stimulants

Stimulants are substances that enhance neural activity and elevate dopamine levels in the brain, leading to their highly addictive nature. These drugs include cocaine, amphetamines, MDMA, caffeine, and nicotine, each with distinct mechanisms of action and varied health implications.
Cocaine can be administered via snorting, injection, or smoking. It primarily functions by blocking the reuptake of dopamine, resulting in a euphoric high characterized by an intense sensation of happiness and...
288
CNS Depressants: Alcohol and Nicotine01:27

CNS Depressants: Alcohol and Nicotine

Ethanol, a clear colorless alcohol, has been consumed by humans for millennia, but its effects on the body are far from benign. At lower doses, it induces decreased inhibitions and loquaciousness, leading to its social appeal. However, it can cause severe consequences at higher doses, such as coma and respiratory depression, due to its zero-order elimination kinetics. Chronic ethanol abuse wreaks havoc on multiple organ systems, particularly the CNS and the liver. Abrupt cessation of ethanol...
335